Levodopa might affect metaiodobenzylguanidine myocardial accumulation

Movement Disorders

Volumn 23, Issue 14, 2008, Pages 2097-2098

  Tateno, Fuyuki ^a   Sakakibara, Ryuji ^a   Saiki, Atsuhito ^a   Miyashita, You ^a   Shirai, Koji ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; AMANTADINE; CARBIDOPA; LEVODOPA; PERGOLIDE MESILATE;

ADULT; ARTICLE; BODY POSTURE; CASE REPORT; DEPRESSION; DISEASE DURATION; DRUG ACCUMULATION; DRUG ANTAGONISM; HAND TREMOR; HEART SCINTISCANNING; HUMAN; IMAGE ANALYSIS; MALE; NEUROLOGIC EXAMINATION; OCCUPATIONAL EXPOSURE; PARKINSONISM; PRIORITY JOURNAL; WALKING DIFFICULTY;

3-IODOBENZYLGUANIDINE; ADULT; DOPAMINE AGENTS; HUMANS; LEVODOPA; MALE; MYOCARDIUM; TREMOR;

EID: 57049170817     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22015     Document Type: Article

References (5)

1. Chaudhuri KR, Healy DG, Schapira AHV. National Institute for Clinical Excellence. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006;5:235-245.
2. Yamashina S, Yamazaki J. Neuronal imaging using SPECT. Eur J Nucl Med Mol Imaging 2007;34:939-950.
3. Orimo S, Takahashi A, Uchihara T, et al. Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease. Brain Pathol 2007;17:24-30.
4. Lode HN, Bruchelt G, Seitz G, et al. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of monoamine transporters in neuroblastoma cell lines: correlations to meta-iodobenzylguanidine (MIBG) uptake and tyrosine hydroxylase gene expression. Eur J Cancer A 1995;31:586-590.
5. Sawka AM, Young WF, Schaff HV. Cardiac phaeochromocytoma presenting with severe hypertension and chest pain. Clin Endocrinol 2001;54:689-692.